NCT01598012View on ClinicalTrials.gov

The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Primary Dysmenorrhea
Interventions
DRUG

Ayurved Siriraj Prasaplai with or without mefenamic acid

Prasaplai in capsule, 2 cap three times a day for 3 days. Mefenamic acid 500 mg prn for severe pain (as rescue medication)

DRUG

Placebo with or without mefenamic acid

Placebo in capsule (physically identical appearance as Prasaplai) 2 cap three times a day for 3 days. Mefenamic acid 500 mg prn for severe pain, every 6 hours (rescue medication)

Trial Locations (1)

10700

Gynecologic Endocrinology Unit, Department of Obstetric and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01598012 - The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter